Graphiti – fast (<1h) phenotypic AST
Bringing fast (1h) phenotypic AST using patented graphene sensing technology
Save time and lives. Perform fast and highly parallelized AST on single cell level.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Research
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- RTI
- GII
- CNSI
- IAI
- SSI
- STI
- SSTI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Looking for partners that can help validate and build our technology and business.
Graphiti is a pre start-up initiative aiming to bring fast (<1h) phenotypic Antimicrobial Susceptibility testing
Able to provide research services to (academic) hospitals, pharma discovery projects and diagnostic centers.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!